Global Exocrine Pancreatic Insufficiency Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 97

Report ID: 19599

Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas.
EPI is commonly found in humans affected with Shwachman-Diamond Syndrome and cystic fibrosis. EPI is triggered by the progressive loss of pancreatic cells, which generates the digestive enzymes. EPI disturbs the normal growth, life expectancy and immune response. Diarrhoea, Steatorrhea, fatigue and weight loss are the key symptoms of EPI.
In 2018, the global Exocrine Pancreatic Insufficiency market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Exocrine Pancreatic Insufficiency status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Exocrine Pancreatic Insufficiency development in United States, Europe and China.

The key players covered in this study
Axcan Pharma
Aptalis Pharma
Eli Lilly
Cilian
Nordmark Arzneimittel
Laboratoires Mayoly Spindler
...

Market segment by Type, the product can be split into
Nutritional management
Pancreatic enzyme replacement therapy (PERT)
Life style modifications approach

Market segment by Application, split into
Nutritional management
Pancreatic enzyme replacement therapy (PERT)
Life style modifications approach

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Exocrine Pancreatic Insufficiency status, future forecast, growth opportunity, key market and key players.
To present the Exocrine Pancreatic Insufficiency development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Exocrine Pancreatic Insufficiency are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Exocrine Pancreatic Insufficiency Market Size Growth Rate by Type (2014-2025)
1.4.2 Nutritional management
1.4.3 Pancreatic enzyme replacement therapy (PERT)
1.4.4 Life style modifications approach
1.5 Market by Application
1.5.1 Global Exocrine Pancreatic Insufficiency Market Share by Application (2014-2025)
1.5.2 Nutritional management
1.5.3 Pancreatic enzyme replacement therapy (PERT)
1.5.4 Life style modifications approach
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Exocrine Pancreatic Insufficiency Market Size
2.2 Exocrine Pancreatic Insufficiency Growth Trends by Regions
2.2.1 Exocrine Pancreatic Insufficiency Market Size by Regions (2014-2025)
2.2.2 Exocrine Pancreatic Insufficiency Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Exocrine Pancreatic Insufficiency Market Size by Manufacturers
3.1.1 Global Exocrine Pancreatic Insufficiency Revenue by Manufacturers (2014-2019)
3.1.2 Global Exocrine Pancreatic Insufficiency Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Exocrine Pancreatic Insufficiency Market Concentration Ratio (CR5 and HHI)
3.2 Exocrine Pancreatic Insufficiency Key Players Head office and Area Served
3.3 Key Players Exocrine Pancreatic Insufficiency Product/Solution/Service
3.4 Date of Enter into Exocrine Pancreatic Insufficiency Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Exocrine Pancreatic Insufficiency Market Size by Type (2014-2019)
4.2 Global Exocrine Pancreatic Insufficiency Market Size by Application (2014-2019)

5 United States
5.1 United States Exocrine Pancreatic Insufficiency Market Size (2014-2019)
5.2 Exocrine Pancreatic Insufficiency Key Players in United States
5.3 United States Exocrine Pancreatic Insufficiency Market Size by Type
5.4 United States Exocrine Pancreatic Insufficiency Market Size by Application

6 Europe
6.1 Europe Exocrine Pancreatic Insufficiency Market Size (2014-2019)
6.2 Exocrine Pancreatic Insufficiency Key Players in Europe
6.3 Europe Exocrine Pancreatic Insufficiency Market Size by Type
6.4 Europe Exocrine Pancreatic Insufficiency Market Size by Application

7 China
7.1 China Exocrine Pancreatic Insufficiency Market Size (2014-2019)
7.2 Exocrine Pancreatic Insufficiency Key Players in China
7.3 China Exocrine Pancreatic Insufficiency Market Size by Type
7.4 China Exocrine Pancreatic Insufficiency Market Size by Application

8 Japan
8.1 Japan Exocrine Pancreatic Insufficiency Market Size (2014-2019)
8.2 Exocrine Pancreatic Insufficiency Key Players in Japan
8.3 Japan Exocrine Pancreatic Insufficiency Market Size by Type
8.4 Japan Exocrine Pancreatic Insufficiency Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Exocrine Pancreatic Insufficiency Market Size (2014-2019)
9.2 Exocrine Pancreatic Insufficiency Key Players in Southeast Asia
9.3 Southeast Asia Exocrine Pancreatic Insufficiency Market Size by Type
9.4 Southeast Asia Exocrine Pancreatic Insufficiency Market Size by Application

10 India
10.1 India Exocrine Pancreatic Insufficiency Market Size (2014-2019)
10.2 Exocrine Pancreatic Insufficiency Key Players in India
10.3 India Exocrine Pancreatic Insufficiency Market Size by Type
10.4 India Exocrine Pancreatic Insufficiency Market Size by Application

11 Central & South America
11.1 Central & South America Exocrine Pancreatic Insufficiency Market Size (2014-2019)
11.2 Exocrine Pancreatic Insufficiency Key Players in Central & South America
11.3 Central & South America Exocrine Pancreatic Insufficiency Market Size by Type
11.4 Central & South America Exocrine Pancreatic Insufficiency Market Size by Application

12 International Players Profiles
12.1 Axcan Pharma
12.1.1 Axcan Pharma Company Details
12.1.2 Company Description and Business Overview
12.1.3 Exocrine Pancreatic Insufficiency Introduction
12.1.4 Axcan Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
12.1.5 Axcan Pharma Recent Development
12.2 Aptalis Pharma
12.2.1 Aptalis Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Exocrine Pancreatic Insufficiency Introduction
12.2.4 Aptalis Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
12.2.5 Aptalis Pharma Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Exocrine Pancreatic Insufficiency Introduction
12.3.4 Eli Lilly Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 Cilian
12.4.1 Cilian Company Details
12.4.2 Company Description and Business Overview
12.4.3 Exocrine Pancreatic Insufficiency Introduction
12.4.4 Cilian Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
12.4.5 Cilian Recent Development
12.5 Nordmark Arzneimittel
12.5.1 Nordmark Arzneimittel Company Details
12.5.2 Company Description and Business Overview
12.5.3 Exocrine Pancreatic Insufficiency Introduction
12.5.4 Nordmark Arzneimittel Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
12.5.5 Nordmark Arzneimittel Recent Development
12.6 Laboratoires Mayoly Spindler
12.6.1 Laboratoires Mayoly Spindler Company Details
12.6.2 Company Description and Business Overview
12.6.3 Exocrine Pancreatic Insufficiency Introduction
12.6.4 Laboratoires Mayoly Spindler Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
12.6.5 Laboratoires Mayoly Spindler Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details